about
Macrophage in chronic kidney diseaseCannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality.Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammationIRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.An oligodeoxynucleotide with AAAG repeats significantly attenuates burn-induced systemic inflammatory responses via inhibiting interferon regulatory factor 5 pathwayIRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in miceMacrophage heterogeneity in the context of rheumatoid arthritis.Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy.Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.Synovial tissue macrophages: friend or foe?Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens.Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study.Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus.Dual role of YM1+ M2 macrophages in allergic lung inflammation.Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to MicrogliaMacrophages: friend or foe in idiopathic pulmonary fibrosis?
P2860
Q28068907-A8D706BB-DE15-4EBC-8473-2997DD4C3363Q33579016-D8A6FED3-9968-40C4-B84D-BE709A06E2F6Q37144586-DE3FABBB-94EE-488A-9749-52B8B7FBEDE2Q37466119-F531343B-8DC1-4BFB-A2DA-14B74E2969D1Q37469202-6A690B05-40B9-4FD5-99C9-FE1A4EDFCDF2Q38723068-5DBECBF9-0383-492E-B89A-60638119AD87Q38780046-8DC8E81F-E5B0-484A-8EC8-839D490B33D4Q38844780-97519293-F76C-4B3A-92EE-A668480C75E2Q42358931-9FFAC8E6-64BD-44FC-97CE-10912EBC684EQ46376898-DB9B471F-8D9E-4E2E-85E9-F64D7A4E55A0Q47189951-48362DA1-240B-429A-A1E8-955487D4291EQ47212014-F3542D8F-6E79-4F74-94DF-60D6790B9A30Q47548122-3F5A186C-581C-4272-8143-65470ADDE12BQ52310633-FB321B84-C4BD-481E-B46C-53C9DCE724F3Q54207404-B8D285E2-3430-4575-8915-5F7F6275387AQ54921770-7EC72696-8C94-4B7F-B1C5-8591E2F23F64Q56889324-094B2B3C-4655-43A1-BA8B-EE5FC28849BAQ58761750-745AF2B3-06FC-4A93-8A79-64E410F0F717
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IRF5 controls both acute and chronic inflammation.
@ast
IRF5 controls both acute and chronic inflammation.
@en
type
label
IRF5 controls both acute and chronic inflammation.
@ast
IRF5 controls both acute and chronic inflammation.
@en
prefLabel
IRF5 controls both acute and chronic inflammation.
@ast
IRF5 controls both acute and chronic inflammation.
@en
P2093
P2860
P356
P1476
IRF5 controls both acute and chronic inflammation
@en
P2093
Dany Perocheau
David G Saliba
James E Pease
Katrina Blazek
Marc Feldmann
Miriam Weiss
P2860
P304
11001-11006
P356
10.1073/PNAS.1506254112
P407
P577
2015-08-17T00:00:00Z